Psychemedics (NASDAQ: PMD)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-09 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.010 | ||||||
REV | 6.508M |
You can purchase shares of Psychemedics (NASDAQ: PMD) through any online brokerage.
Other companies in Psychemedics’s space includes: Aesthetic Medical Intl (NASDAQ:AIH), Precipio (NASDAQ:PRPO), Star Equity Hldgs (NASDAQ:STRR), Novo Integrated Sciences (NASDAQ:NVOS) and Akumin (NASDAQ:AKU).
There is no analysis for Psychemedics
The stock price for Psychemedics (NASDAQ: PMD) is $6.18 last updated July 1, 2022, 8:00 PM UTC.
A quarterly cash dividend of $0.07 per share of Class A Common Stock. The quarterly cash dividend was payable on June 24, 2022 to stockholders of record on May 26, 2022.
Psychemedics’s Q2 earnings are confirmed for Tuesday, August 9, 2022.
There is no upcoming split for Psychemedics.
Psychemedics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.